2 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow M-VAC protocol: new trials by email Literature Review of M-VAC protocol trials Research Report on M-VAC protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma Durvalumab, Tremelimumab, MVAC Protocol - Infiltrating Bladder Urothelial Carcinoma | Phase 1 / Phase 2 | Unknown | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | 121 | 2018-12-06 | 2024-03-06 |
| Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma RNU, Gemcitabine/Cisplatin, M-VAC Protocol - Upper Tract Urothelial Carcinoma | Phase 2 | Unknown | The European Uro-Oncology Group | 200 | 2018-05-28 | 2023-12-18 |
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (1) · The European Uro-Oncology Group (1)
France (1) · Netherlands (1) · Norway (1) · Spain (1)